Skip to main content
Fig. 1 | Trials

Fig. 1

From: Results and lessons learnt from a randomized controlled trial: prophylactic treatment of vestibular migraine with metoprolol (PROVEMIG)

Fig. 1

Consolidated Standards of Reporting Trials (CONSORT) 2010 flow diagram together with patient-reported outcome specific information. Enrolment and primary efficacy end points based on patient diaries. The steps lead from pre-screening to collection of the data used in the efficacy analyses. The diagram shows the extent of exclusions, loss to follow-up and missing data within the 6-month treatment period (diary information unavailable means no diary at all within the time period of primary interest, day 91 to day 180). *Diagnostic criteria according to Neuhauser 2001 [2]. †Baseline frequency of vertigo attacks in the last 3 subsequent months prior to enrolment. Per protocol: treatment duration >90 days, counting from day of first intake. FAS full analysis set

Back to article page